PMID- 21435137 OWN - NLM STAT- MEDLINE DCOM- 20120321 LR - 20211020 IS - 1399-5448 (Electronic) IS - 1399-543X (Print) IS - 1399-543X (Linking) VI - 12 IP - 8 DP - 2011 Dec TI - Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). PG - 669-75 LID - 10.1111/j.1399-5448.2011.00760.x [doi] AB - AIM: We investigated whether omega-3 fatty acid intake and erythrocyte membrane omega-3 fatty acid levels are associated with conversion to type 1 diabetes in children with islet autoimmunity (IA). METHODS: The Diabetes Autoimmunity Study in the Young is following children at increased genetic risk for type 1 diabetes for the development of persistent IA, as defined as being positive for glutamic acid decarboxylase 65, i, or insulin autoantibodies on two consecutive visits, and then for the development of type 1 diabetes, as diagnosed by a physician. One hundred and sixty-seven children with persistent IA were followed for a mean of 4.8 yr, and 45 of these developed type 1 diabetes at a mean age of 8.7 yr. Erythrocyte membrane fatty acids (as a percent of total lipid) and dietary fatty acid intake (estimated via food frequency questionnaire) were analyzed as time-varying covariates in proportional hazards survival analysis, with follow-up time starting at detection of the first autoantibody. RESULTS: Neither dietary intake of omega-3 fatty acids nor omega-6 fatty acids were associated with conversion to type 1 diabetes, adjusting for human leukocyte antigen (HLA)-DR, family history of type 1 diabetes, age at first IA positivity, maternal age, maternal education, and maternal ethnicity. Adjusting for HLA-DR, family history of type 1 diabetes and age at first IA positivity, omega-3 and omega-6 fatty acid levels of erythrocyte membranes were not associated with conversion to type 1 diabetes. CONCLUSIONS: In this observational study, omega-3 fatty acid intake and status are not associated with conversion to type 1 diabetes in children with IA. CI - (c) 2011 John Wiley & Sons A/S. FAU - Miller, Melissa R AU - Miller MR AD - Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Campus Box B119, Aurora, CO 80045, USA. FAU - Yin, Xiang AU - Yin X FAU - Seifert, Jennifer AU - Seifert J FAU - Clare-Salzler, Michael AU - Clare-Salzler M FAU - Eisenbarth, George S AU - Eisenbarth GS FAU - Rewers, Marian AU - Rewers M FAU - Norris, Jill M AU - Norris JM LA - eng GR - P30 DK057516/DK/NIDDK NIH HHS/United States GR - P30 DK 57516/DK/NIDDK NIH HHS/United States GR - R01 DK049654/DK/NIDDK NIH HHS/United States GR - R01 DK032493/DK/NIDDK NIH HHS/United States GR - R01-DK32493/DK/NIDDK NIH HHS/United States GR - R01-DK49654/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20110324 PL - Denmark TA - Pediatr Diabetes JT - Pediatric diabetes JID - 100939345 RN - 0 (Autoantibodies) RN - 0 (Dietary Fats, Unsaturated) RN - 0 (Fatty Acids, Omega-3) RN - 0 (Fatty Acids, Omega-6) SB - IM MH - Autoantibodies/*blood MH - Autoimmunity/genetics MH - Child MH - Diabetes Mellitus, Type 1/*genetics MH - Dietary Fats, Unsaturated/administration & dosage MH - Erythrocyte Membrane/*chemistry MH - Fatty Acids, Omega-3/administration & dosage/*blood MH - Fatty Acids, Omega-6/blood MH - Female MH - Follow-Up Studies MH - Humans MH - Infant MH - Islets of Langerhans/*immunology MH - Male PMC - PMC3475955 MID - NIHMS409492 COIS- Conflict of interest The authors declare no conflict of interest. EDAT- 2011/03/26 06:00 MHDA- 2012/03/22 06:00 PMCR- 2012/10/19 CRDT- 2011/03/26 06:00 PHST- 2011/03/26 06:00 [entrez] PHST- 2011/03/26 06:00 [pubmed] PHST- 2012/03/22 06:00 [medline] PHST- 2012/10/19 00:00 [pmc-release] AID - 10.1111/j.1399-5448.2011.00760.x [doi] PST - ppublish SO - Pediatr Diabetes. 2011 Dec;12(8):669-75. doi: 10.1111/j.1399-5448.2011.00760.x. Epub 2011 Mar 24.